Combination treatment for osteoporosis with multiple fractures
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether taking two osteoporosis medicines together (romosozumab and denosumab) can help prevent more broken bones in women after menopause who have already had several fractures. It may be a good option if you have weak bones and want to lower your risk of future breaks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause.
- You have been diagnosed with osteoporosis (weak bones).
- You are between 55 and 85 years old.
- You have had more than one broken bone that happened after a minor fall or bump.
- You have not had a stroke or heart attack in the past.
- You do not have kidney disease or problems with calcium in your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for osteoporosis in postmenopausal women: a sequence of romosozumab followed by denosumab versus zoledronic acid alone. The goal is to see which approach better improves bone density in the hip. Participants will receive either the combination or the single drug for a period, and their progress will be monitored.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
This trial is testing a medicine called romosozumab to treat postmenopausal women with severe osteoporosis and a recent fracture. It aims to find the best way to use this drug to strengthen bones and prevent more fractures.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at what medicine works best for women who have finished a 1-year course of a strong bone-building drug (romosozumab or teriparatide) for severe osteoporosis. The goal is to find a good follow-up treatment to keep bones strong and prevent fractures.
Hear when a new Osteoporosis in Post-menopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.